22-42129770-G-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_000106.6(CYP2D6):​c.320C>A​(p.Thr107Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000236 in 1,608,900 control chromosomes in the GnomAD database, including 16 homozygotes. There is a variant allele frequency bias in the population database for this variant (GnomAd4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T107I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00079 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 13 hom. )

Consequence

CYP2D6
NM_000106.6 missense

Scores

18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.91

Publications

219 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006817639).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000106.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2D6
NM_000106.6
MANE Select
c.320C>Ap.Thr107Asn
missense
Exon 2 of 9NP_000097.3
CYP2D6
NM_001025161.3
c.320C>Ap.Thr107Asn
missense
Exon 2 of 8NP_001020332.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP2D6
ENST00000645361.2
MANE Select
c.320C>Ap.Thr107Asn
missense
Exon 2 of 9ENSP00000496150.1
CYP2D6
ENST00000359033.4
TSL:1
c.320C>Ap.Thr107Asn
missense
Exon 2 of 8ENSP00000351927.4
CYP2D6
ENST00000360124.10
TSL:1
n.320C>A
non_coding_transcript_exon
Exon 2 of 8ENSP00000353241.6

Frequencies

GnomAD3 genomes
AF:
0.000793
AC:
120
AN:
151272
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000244
Gnomad AMI
AF:
0.0336
Gnomad AMR
AF:
0.00507
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.000625
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000164
AC:
40
AN:
244170
AF XY:
0.000142
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000915
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000547
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.000178
AC:
260
AN:
1457518
Hom.:
13
Cov.:
33
AF XY:
0.000165
AC XY:
120
AN XY:
725176
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000300
AC:
1
AN:
33338
American (AMR)
AF:
0.00393
AC:
174
AN:
44226
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39586
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86104
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52118
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000550
AC:
61
AN:
1110066
Other (OTH)
AF:
0.000133
AC:
8
AN:
60198
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.285
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000793
AC:
120
AN:
151382
Hom.:
3
Cov.:
32
AF XY:
0.000933
AC XY:
69
AN XY:
73972
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000244
AC:
1
AN:
41016
American (AMR)
AF:
0.00506
AC:
77
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5144
South Asian (SAS)
AF:
0.000626
AC:
3
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67840
Other (OTH)
AF:
0.000475
AC:
1
AN:
2104
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.345
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
356
ExAC
AF:
0.000827
AC:
100
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.0030
DANN
Benign
0.55
DEOGEN2
Benign
0.0011
T
Eigen
Benign
-2.2
Eigen_PC
Benign
-2.2
FATHMM_MKL
Benign
0.0021
N
LIST_S2
Benign
0.12
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0068
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.025
N
PhyloP100
-2.9
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.26
N
REVEL
Benign
0.14
Sift
Benign
0.31
T
Sift4G
Benign
0.22
T
Vest4
0.12
MutPred
0.52
Gain of relative solvent accessibility (P = 0.0905)
MVP
0.52
MPC
0.13
ClinPred
0.040
T
GERP RS
-1.7
Varity_R
0.19
gMVP
0.72
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28371706; hg19: chr22-42525772; API